Visaka Industrie (VISAKAIND)
TurnaroundFairStock Score: 34/100 — RISKY
Score breakdown: P/E: 2/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹95.46 |
| Market Cap | ₹824.82 Cr |
| P/E Ratio | 9.66 |
| ROCE | 3.5% |
| ROE | 8.44% |
| Dividend Yield | 2.3% |
| Profit Growth | -4.47% |
| Debt/Equity | 0.37 |
| Sales Growth | 16.57% |
| Promoter Holding | 53.24% |
| 52-Week Range | ₹50.2 — ₹104.41 |
| Sector | Cement & Cement Products |
| Book Value | ₹95.7 |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
At ₹64.99, with book value of ₹84.76, I am immediately interested—Graham taught me to buy with a margin of safety, and this is a ~23% discount to net assets. Debt/equity of 0.53 is manageable, and a Piotroski score of 7/9 suggests financial health is improving. Promoter holding of 53.24% aligns owners with shareholders. However, a cheap balance sheet can be a trap. ROCE is only 3.50%, and ROE just 8.44%—this is not a wonderful business. Cement products are capital-intensive, cyclical, and have weak pricing power. Sales growth of 4.59% is pedestrian. The latest quarter delivered only ₹2 crore profit on ₹368 crore sales, a razor-thin margin. The 117.49% profit growth and 0.28 PEG look exciting, but they likely reflect a low base; with a P/E of 17.34, the market is not paying a huge price, but it is also not paying much for growth. In Graham's terms, the asset backing provides a cushion. But Buffett would ask: will the company earn a better return on ₹84.76 of book capital? If not, the discount to book may persist. I need to see sustained margin expansion and ROCE improving toward double digits before classifying this as a real value buy. For now, it is a cyclical with attractive book support but unproven earnings power. I'd keep it on my watchlist and wait for concrete evidence.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer